Skip to main content
SpringerLink
Log in

Oncogenes after Angioplasty

  • Chapter
Arterial Remodeling: A Critical Factor in Restenosis

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 198))

  • 63 Accesses

Abstract

Percutaneous transluminal coronary angioplasty (PTCA) has become a well established technique for myocardial revascularization of patients with coronary artery disease. However, PICA remains limited by restenosis that occurs in 30–60% of cases despite a successful procedure (1,2). Assuming 500,000 PICA procedures per year in the United States (3), more than 150,000 patients develop restenosis every year. Despite intensive investigation in this area, no pharmacological therapy has yet been found to be useful in preventing restenosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. McBride W, Lange RA, Hillis LD. Restenosis after successful coronary angioplasty. Pathophysiology and prevention. N Engl J Med.1988;318:1734–1737

    Article  PubMed  CAS  Google Scholar 

  2. Liu MW, Roubin GS, King III SB. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation. 1989;79: 1374–1387

    Article  PubMed  CAS  Google Scholar 

  3. Hillegass, W.B., Ohman, E.M. and Califf, R.M. Restenosis: The clinical issues. In: Textbook of interventional cardiology, edited by Topol, E.J. philadelphia: WB Saunders, 1994, p. 415–435.

    Google Scholar 

  4. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. 1. Smooth muscle growth in the absence of endothelium. Lab Invest.1983;49:327–333

    PubMed  CAS  Google Scholar 

  5. Clowes AW, Clowes MM. Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin. Lab Invest.1985;52:611–616

    PubMed  CAS  Google Scholar 

  6. Casscells W. Migration of smooth muscle and endothelial cells. Critical events in restenosis. Circulation. 1992;86:723–729

    Article  PubMed  CAS  Google Scholar 

  7. Lafont A, Guzman LA, Whitlow PL, Goormastic M, Comhill JF, Chisolm GM. Restenosis after experimental angioplasty. Intimal, medial, and adventitial changes associated with constrictive remodeling. Circ Res. 1995;76:996–1002

    Article  PubMed  CAS  Google Scholar 

  8. Post MJ, Borst C, Kuntz RE. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and in the hupercholesterolemic Yucatan micropig. Circulation. 1994;89:2816–2821

    Article  PubMed  CAS  Google Scholar 

  9. Kakuta T, Currier JW, Haudenschild CC, Ryan TJ, Faxon DP. Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. Circulation. 1994;89:2809–2815

    Article  PubMed  CAS  Google Scholar 

  10. Bishop JM. The molecular genetics of cancer. Science. 1987;235:305–311

    Article  PubMed  CAS  Google Scholar 

  11. Weinberg RA. The action of oncogenes in the cytoplasm and the nucleus. Science.1985;230:770–776

    Article  PubMed  CAS  Google Scholar 

  12. Bishop JM. Viral oncogenes. Cell.1985;42:23–38

    Article  PubMed  CAS  Google Scholar 

  13. Waterfield MD, Scrace GT, Whittle N, et al. Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature. 1983;304:35–39

    Article  PubMed  CAS  Google Scholar 

  14. Downward J, Yarden Y, Mayes E, et al. Close similarity of epidermal growth factor receptor and verb-B oncogene protein sequences. Nature. 1984;307:521–527

    Article  PubMed  CAS  Google Scholar 

  15. Bos JL, Fearon ER, Hamilton SR, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature. 1987;327:293–297

    Article  PubMed  CAS  Google Scholar 

  16. Schneider MD, Parker TG. Cardiac myocytes as targets for the action of peptide growth factor. Circulation. 1990;81:1443–1456

    Article  PubMed  CAS  Google Scholar 

  17. Pardee AB. G1 events and regulation of cell proliferation. Science. 1989;246:603–608

    Article  PubMed  CAS  Google Scholar 

  18. Reed JC, Alpers JD, Nowell PC, Hoover RG. Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes. Proc Natl Acad Sci USA. 1986;83:3982–3986

    Article  PubMed  CAS  Google Scholar 

  19. Riabowol KT, Vosatka RJ, Ziff EB, Lamb NJ, Feramisco JR. Microinjection of fos-specific antibodies blocks DNA synthesis in fibroblast cells. Mol Cell Biol.1988;8:1670–1676

    PubMed  CAS  Google Scholar 

  20. Nishikura K, Murray JM. Antisense RNA of protooncogene c-fos blocks renewed growth of quiescent 3T3 cells. Mol Cell Biol.1987;7:639–646

    PubMed  CAS  Google Scholar 

  21. Thyberg J, Hedin U, Sjölund M, et al. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis.1990;10:966–990

    Article  PubMed  CAS  Google Scholar 

  22. Schwartz SM, Campbell CR, Campbell JH. Replication of smooth muscle cells in vascular disease. Circ Res. 1986;58:427–444

    Article  PubMed  CAS  Google Scholar 

  23. Schwartz RS, Holmes DR, Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardio1.1992;20:1284–1293

    Article  CAS  Google Scholar 

  24. Bauters C, De Groote P, Adamantidis M, et al. Proto-oncogene expression in rabbit aorta after wall injury. First marker of the cellular process leading to restenosis after angioplasty? Eur Heart J.1992;13:556–559

    PubMed  CAS  Google Scholar 

  25. Miano JM, Viasic N, Tota RR, Stemerman MB. Localisation of fos and jun proteins in rat aortic smooth muscle cells after vascular injury. Am J Pathol.1993;142:715–724

    PubMed  CAS  Google Scholar 

  26. Walker LN, Bowen-Pope DF, Ross R, Reidy MA. Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci USA. 1986;83:7311–7315

    Article  PubMed  CAS  Google Scholar 

  27. Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 1991;253: 1129–1132

    Article  PubMed  CAS  Google Scholar 

  28. Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA.1991;88:3739–3743

    Article  PubMed  CAS  Google Scholar 

  29. Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation. Am J Pathol.1991;68:106–113

    CAS  Google Scholar 

  30. Lindner V, Majack RA, Reidy MA. Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries. J Clin Invest. 1990;85:2004–2008

    Article  PubMed  CAS  Google Scholar 

  31. Cercek B, Fishbein MC, Forrester JS, Helfant RH, Fagin JA. Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation. Circ Res.1990;66:1755–1760

    Article  PubMed  CAS  Google Scholar 

  32. Nikol S, Isner JM, Pickering JG, Kearney M, Leclerc G, Weir L. Expression of transforming growth factor-ßl is increased in human vascular restenosis lesions. J Clin Invest. 1992;90: 1582–1592

    Article  PubMed  CAS  Google Scholar 

  33. Border WA, Ruosslahti E. Transforming growth factor-13 in disease: the dark side of tissue repair. J Clin lnvest.1992;90:l-7

    Article  Google Scholar 

  34. Sporn MB, Roberts AB, Wakefield LM, de Combrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-β. J Cell Bio1.1987;105:1039–1045

    Article  CAS  Google Scholar 

  35. Bauters C, Van Belle E, Wemert N, et al. Angiopeptin inhibits oncogene induction in rabbit aorta after balloon denudation. Circulation.1994;89:2327–2331

    Article  PubMed  CAS  Google Scholar 

  36. Colas B, Cambillau C, Buscail L, et al. Stimulation of a membrane tyrosine phosphatase activity by somatostatin analogues in rat pancreatic acinar cells. Eur J Biochem.1992;207:1017–1024

    Article  PubMed  CAS  Google Scholar 

  37. Hierowski MT, Liebow C, DuSpain K, Schally AV. Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer MIA paCa-2 cell line. FEBS Lett. 1985;179:252–256

    Article  PubMed  CAS  Google Scholar 

  38. Van Belle E, Bauters C, Wemert N, et al. Angiotensin converting enzyme inhibition prevents protooncogene expression in the vascular wall after injury. J Hypertension.1995;13:105–112

    Article  CAS  Google Scholar 

  39. Kulik TJ, Rothman A, Glennon ET, Underwood RH. Stretching vascular smooth muscle causes inositol phosphates turnover. Circulation.1989;80:II-198

    Google Scholar 

  40. Simons M, Edelman ER, DeKeyser J, Langer R, Rosenberg R. Antisense c-myb oligonucleotides inhibit arterial smooth muscle cell accumulation in vivo. Nature. 1992;359:67–70

    Article  PubMed  CAS  Google Scholar 

  41. Bennett MR, Anglin S, McEwan JR, Jagoe R, Newby AC, Evan GI. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. J Clin Invest. 1994;93:820–828

    Article  PubMed  CAS  Google Scholar 

  42. Shi Y, Fard A, Galeo A, et al. Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury. Circulation. 1994;90:944–951

    Article  PubMed  CAS  Google Scholar 

  43. Kim SJ, Angel P, Lafyatis R, et al. Autoinduction of transforming growth factor ßl is mediated by the AP-1 complex. Mol Cell Bio1.1990;10:1492–1497

    CAS  Google Scholar 

  44. Schontal A, Herrlich P, Rahmsdorf HJ, Ponta H. Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell.1988;54:325–334

    Article  Google Scholar 

  45. Nerlov C, Rorth P, Blasi F, Johnsen M. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene.1991;6:1583–1592

    PubMed  CAS  Google Scholar 

  46. Clowes AW, Clowes MM, Au YPT, Reidy MA, Belin D. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res.1990;67:61–67

    Article  PubMed  CAS  Google Scholar 

  47. Pettinen RP, Kobayashi S, Bornstein P. Transforming growth factor-0 increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. Proc Natl Acad Sci USA.1988; 85:1105–1108

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de Cardiologie B, Hôpital Cardiologique, Lille, France

    Christophe Bauters, Thibaud Meurice, Eugène McFadden, Jean-Marc Lablanche & Michel E. Bertrand

Authors
  1. Christophe Bauters
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thibaud Meurice
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eugène McFadden
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jean-Marc Lablanche
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michel E. Bertrand
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Necker University, Paris, France

    Antoine Lafont

  2. Cleveland Clinic Foundation, Cleveland, Ohio, USA

    Eric J. Topol

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media New York

About this chapter

Cite this chapter

Bauters, C., Meurice, T., McFadden, E., Lablanche, JM., Bertrand, M.E. (1997). Oncogenes after Angioplasty. In: Lafont, A., Topol, E.J. (eds) Arterial Remodeling: A Critical Factor in Restenosis. Developments in Cardiovascular Medicine, vol 198. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-6079-1_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-6079-1_19

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7785-6

  • Online ISBN: 978-1-4615-6079-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation